345.74  -1.24 (-0.36%)		01-30 15:51
Open: 347.9 High: 350.84 Volume: 1,020,219		Pre. Close: 346.98 Low: 342.01 Market Cap: 76,837(M)

Short term
Mid term
Targets	6-month :	447.34	1-year :	522.49
Resists	First :	383	Second :	447.34
Pivot price	364.1
Supports	First :	332.1	Second :	300.64
MAs	MA(5) :	346.64	MA(20) :	364.6
	MA(100) :	339.69	MA(250) :	360.17
MACD	MACD :	-1.1	Signal :	3.5
%K %D	K(14,3) :	53.2	D(3) :	44.9
RSI	RSI(14): 44.1
52-week	High :	458.75	Low :	273.7

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ ELV ] has closed above bottom band by 19.8%. Bollinger Bands are 72.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	351.18 - 352.6	352.6 - 353.95
Low:	337.53 - 339.1	339.1 - 340.59
Close:	344.47 - 346.93	346.93 - 349.27

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Fri, 30 Jan 2026
Elevance Health (ELV): Wells Fargo Lowers Price Target, Maintains Overweight Rating | ELV Stock News - GuruFocus

Thu, 29 Jan 2026
Analyst Expectations For Elevance Health's Future - Benzinga

Thu, 29 Jan 2026
Elevance Health Inc. (NYSE:ELV) Q4 2025 Earnings Call Transcript - Insider Monkey

Wed, 28 Jan 2026
Elevance Health Inc (ELV) Q4 2025 Earnings Call Highlights: Stro - GuruFocus

Wed, 28 Jan 2026
Elevance Health Q4 Earnings Review: No Sign Of An End To The Pain (NYSE:ELV) - Seeking Alpha

Wed, 28 Jan 2026
Elevance Health (ELV) Deep-Dive: Navigating the 2026 Regulatory Storm and the Carelon Transformation - FinancialContent

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Healthcare Plans
Shares Out	222 (M)
Shares Float	222 (M)
Held by Insiders	0.1 (%)
Held by Institutions	92 (%)
Shares Short	4,100 (K)
Shares Short P.Month	3,880 (K)

EPS	24.54
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	197.94
Profit Margin	2.8 %
Operating Margin	3.4 %
Return on Assets (ttm)	4.2 %
Return on Equity (ttm)	12.5 %
Qtrly Rev. Growth	12.3 %
Gross Profit (p.s.)	230.2
Sales Per Share	876.61
EBITDA (p.s.)	40.13
Qtrly Earnings Growth	22 %
Operating Cash Flow	4,910 (M)
Levered Free Cash Flow	5,120 (M)

PE Ratio	14.03
PEG Ratio	0
Price to Book value	1.74
Price to Sales	0.39
Price to Cash Flow	15.59

Dividend	1.71
Forward Dividend	0
Dividend Yield	0.4%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.